We are live on
!
Find out more
DCP
Distillate Capital Partners Portfolio holdings
AUM
$1.9B
1-Year Est. Return
2.22%
This Fund
S&P 500
This Quarter
Est. Return
+7.54%
1 Year Est. Return
-2.22%
3 Year Est. Return
+17.78%
5 Year Est. Return
+50.1%
10 Year Est. Return
–
AUM
$390K
AUM Growth
-$693K
(-64%)
Cap. Flow
-$730K
Cap. Flow
% of AUM
-187.32%
Top 10 Holdings %
Top 10 Hldgs %
34.93%
Holding
108
New
8
Increased
18
Reduced
4
Closed
75
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pultegroup
PHM
|
+$13.2K |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$12.1K |
| 3 |
GoDaddy
GDDY
|
+$11.7K |
| 4 |
PayPal
PYPL
|
+$11.6K |
| 5 |
Albertsons Companies
ACI
|
+$11.2K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$17.4K |
| 2 |
Halliburton
HAL
|
+$14.8K |
| 3 |
Moderna
MRNA
|
+$14.5K |
| 4 |
Gilead Sciences
GILD
|
+$13.7K |
| 5 |
Steel Dynamics
STLD
|
+$12.9K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 38.91% |
| 2 | Healthcare | 16.45% |
| 3 | Industrials | 8.82% |
| 4 | Communication Services | 6.67% |
| 5 | Consumer Discretionary | 6.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Jazz Pharmaceuticals
JAZZ
$16.3B
| $10.5K | 2.7% |
+72
| New | +$10.7K |
|
27
CBRE Group
CBRE
$43.7B
| $10.5K | 2.69% |
144
+4
| +3% | +$327 |
|
28
Amgen
AMGN
$218B
| $10.4K | 2.67% |
43
| – | – |
|
29
3M
MMM
$94.1B
| $9.67K | 2.48% |
110
+6
| +6% | +$566 |
|
|
EXE
30
Expand Energy Corp
EXE
$21.1B
| $9.66K | 2.48% |
127
+26
| +26% | +$2.14K |
|
31
CVS Health
CVS
$127B
| $8.99K | 2.31% |
121
+20
| +20% | +$1.68K |
|
32
Fidelity National Information Services
FIS
$22.2B
| $8.96K | 2.3% |
165
+36
| +28% | +$2.34K |
|
|
AACI
33
DELISTED
Armada Acquisition Corp. I Common Stock
AACI
| $8.94K | 2.3% |
+35
| New | +$354 |
|
34
Advanced Micro Devices
AMD
$793B
| – | – |
-149
| Closed | -$9.65K |
|
35
APA Corp
APA
$12.4B
| – | – |
-266
| Closed | -$12.4K |
|
36
Apollo Global Management
APO
$73.9B
| – | – |
-201
| Closed | -$12.8K |
|
37
Antero Resources
AR
$10.7B
| – | – |
-318
| Closed | -$9.86K |
|
38
Best Buy
BBY
$17.8B
| – | – |
-154
| Closed | -$12.4K |
|
39
Cardinal Health
CAH
$55.8B
| – | – |
-146
| Closed | -$11.2K |
|
40
CF Industries
CF
$17.9B
| – | – |
-100
| Closed | -$8.52K |
|
41
Cigna
CI
$71.7B
| – | – |
-35
| Closed | -$11.6K |
|
42
Cummins
CMI
$90.4B
| – | – |
-48
| Closed | -$11.6K |
|
43
ConocoPhillips
COP
$141B
| – | – |
-91
| Closed | -$10.7K |
|
44
Cencora
COR
$62.1B
| – | – |
-71
| Closed | -$11.8K |
|
|
CTRA
45
DELISTED
Coterra Energy
CTRA
| – | – |
-364
| Closed | -$8.94K |
|
46
Chevron
CVX
$372B
| – | – |
-66
| Closed | -$11.8K |
|
47
Darling Ingredients
DAR
$9.27B
| – | – |
-144
| Closed | -$9.01K |
|
48
Dell
DELL
$308B
| – | – |
-276
| Closed | -$11.1K |
|
49
D.R. Horton
DHI
$42.3B
| – | – |
-141
| Closed | -$12.6K |
|
50
HF Sinclair
DINO
$15.1B
| – | – |
-178
| Closed | -$9.24K |
|
Similar funds
EP
FTCM
IAN
BOH
VC
MC
TF
SGF
Distillate Capital Partners's Q1 2023 Portfolio in Review
As of Q1 2023, Distillate Capital Partners held 108 positions worth $390K, down 64% from $1.08M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Distillate Capital Partners withdrew a net $730K in Q1 2023, closing 75 positions and reducing 4 holdings. Its most notable exit was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $17.4K position sold in full.
By sector, the portfolio is most concentrated in Technology at 39% of assets, up from 19% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Distillate Capital Partners opened a new position in Pultegroup worth $14.2K.
- Distillate Capital Partners's largest Q1 2023 buy was Pultegroup: 244 shares worth $14.2K.
- Distillate Capital Partners added most to Fidelity National Information Services in Q1 2023, an estimated $2.34K increase.
- Distillate Capital Partners's biggest Q1 2023 reduction was Omnicom Group, cutting an estimated $1.68K.
- Distillate Capital Partners fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2023, selling an estimated $17.4K.
- Distillate Capital Partners's ten largest holdings make up 35% of its $390K portfolio in Q1 2023.
- Distillate Capital Partners opened 8 new positions and closed 75 in Q1 2023.
- Distillate Capital Partners's portfolio value fell 64% quarter-over-quarter to $390K.
Based on Distillate Capital Partners's 13F filing for Q1 2023, filed 15 May 2023.